All stock lists
Unlock the score
General American Investors Co Inc (New York Stock Exchange:GAM)
US · Delayed Price · Currency is USD
Financial Services · Asset Management
64.13+0.41 (+0.64%)
Market cap
$1.54B
Insider Score
Health Score
Listed since
Mar 17, 1980
Website
Insider Score
/ 100
GAM Insider Score
GENERAL AMERICAN INVESTORS CO INC has a live Insider Score.
Scored on 6 qualifying trades from 4 insiders in the last 90 days.
Financial Health Score
Sound
From GAM’s reported statements · Q2 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $24.4M
- Net income
- $376.7M
- Net margin
- 1542.3%
Leverage17 / 20
Little or no net debt.
- Total debt
- $1.5M
- Cash
- $74K
- Net debt / EBITDA
- 0.53x
Liquidity3 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $15.7M
- Current liabilities
- $22.7M
- Current ratio
- 0.69
Cash generation11 / 20
Roughly cash-neutral.
- Operating cash flow
- $0
- Free cash flow
- $0
- FCF margin
- 0.0%
Dilution & runway18 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 23.8M
- Share growth (1y)
- 2.4%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
GAM Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 6.34 M | 6.34 M | 5.87 M | 5.87 M | 6.28 M | 6.28 M |
| Revenue Growth (YoY) | 0.91 % | 0.91 % | -22.13 % | -22.13 % | -14.24 % | -84.87 % |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 6.34 M | 6.34 M | 5.87 M | 5.87 M | 6.28 M | 6.28 M |
| SG&A Expense | 3.45 M | 3.45 M | 4.47 M | 4.47 M | 3.26 M | 3.26 M |
| R&D Expense | 1.98 M | 1.98 M | 2.90 M | 2.90 M | 1.87 M | 1.87 M |
| Operating Expenses | 5.44 M | 5.44 M | 7.37 M | 7.37 M | 5.13 M | 5.13 M |
| Operating Income | 898.04 K | 898.04 K | -1.50 M | -1.50 M | 1.15 M | 1.15 M |
| Pretax Income | 93.60 M | 93.60 M | 94.73 M | 94.73 M | 75.19 M | 75.19 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 93.60 M | 93.60 M | 94.73 M | 94.73 M | 75.19 M | 75.19 M |
| EPS (Basic) | 3.81 | 3.81 | 3.83 | 3.83 | 3.11 | 3.11 |
| EPS (Diluted) | 3.81 | 3.81 | 3.83 | 3.83 | 3.11 | 3.11 |
| Shares Outstanding | 23.83 M | 23.83 M | 24.02 M | 24.02 M | 23.28 M | 23.28 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.